= 0 1 0 1 O
< 1 2 1 2 O
3 3 4 3 4 B-upper_bound
times 5 10 5 10 I-upper_bound
ULN 11 14 11 14 I-upper_bound
in 15 17 15 17 O
case 18 22 18 22 O
of 23 25 23 25 O
liver 26 31 26 31 B-cancer
metastasis 32 42 32 42 I-cancer

= 0 1 43 44 O
< 1 2 44 45 O
5 3 4 46 47 B-upper_bound
times 5 10 48 53 I-upper_bound
ULN 11 14 54 57 I-upper_bound
in 15 17 58 60 O
case 18 22 61 65 O
of 23 25 66 68 O
liver 26 31 69 74 B-cancer
metastasis 32 42 75 85 I-cancer

A 0 1 86 87 O
FOCBP 2 7 88 93 O
is 8 10 94 96 O
any 11 14 97 100 O
woman 15 20 101 106 B-gender
( 21 22 107 108 O
regardless 22 32 108 118 O
of 33 35 119 121 O
sexual 36 42 122 128 O
orientation 43 54 129 140 O
, 54 55 140 141 O
having 56 62 142 148 O
undergone 63 72 149 158 O
a 73 74 159 160 O
tubal 75 80 161 166 B-treatment
ligation 81 89 167 175 I-treatment
, 89 90 175 176 O
or 91 93 177 179 O
remaining 94 103 180 189 O
celibate 104 112 190 198 O
by 113 115 199 201 O
choice 116 122 202 208 O
) 122 123 208 209 O

Absolute 0 8 210 218 B-clinical_variable
neutrophil 9 19 219 229 I-clinical_variable
count 20 25 230 235 I-clinical_variable
> 26 27 236 237 O
= 27 28 237 238 O
1,000 29 34 239 244 B-lower_bound
/ 34 35 244 245 I-lower_bound
mcL 35 38 245 248 I-lower_bound

Completion 0 10 249 259 O
of 11 13 260 262 O
prior 14 19 263 268 B-treatment
chemotherapy 20 32 269 281 I-treatment
systemic 33 41 282 290 I-treatment
anticancer 42 52 291 301 I-treatment
therapy 53 60 302 309 I-treatment
at 61 63 310 312 O
least 64 69 313 318 O
2 70 71 319 320 B-lower_bound
weeks 72 77 321 326 I-lower_bound
prior 78 83 327 332 I-lower_bound
to 84 86 333 335 O
study 87 92 336 341 O
entry 93 98 342 347 O

Creatinine 0 10 348 358 B-clinical_variable
= 11 12 359 360 O
< 12 13 360 361 O
2 14 15 362 363 B-upper_bound
ng 16 18 364 366 I-upper_bound
/ 18 19 366 367 I-upper_bound
ml 19 21 367 369 I-upper_bound

Current 0 7 370 377 O
or 8 10 378 380 O
prior 11 16 381 386 B-treatment
use 17 20 387 390 I-treatment
of 21 23 391 393 I-treatment
immunosuppressive 24 41 394 411 I-treatment
therapy 42 49 412 419 I-treatment
within 50 56 420 426 O
2 57 58 427 428 B-upper_bound
weeks 59 64 429 434 I-upper_bound
of 65 67 435 437 O
starting 68 76 438 446 O
investigational 77 92 447 462 B-treatment
therapy 93 100 463 470 I-treatment

FOCBP 0 5 471 476 O
must 6 10 477 481 O
have 11 15 482 486 O
a 16 17 487 488 O
negative 18 26 489 497 B-pregnancy
pregnancy 27 36 498 507 I-pregnancy
test 37 41 508 512 O
within 42 48 513 519 O
7 49 50 520 521 B-upper_bound
days 51 55 522 526 I-upper_bound
prior 56 61 527 532 I-upper_bound
to 62 64 533 535 O
registration 65 77 536 548 O
on 78 80 549 551 O
study 81 86 552 557 O

Female 0 6 558 564 B-gender
patients 7 15 565 573 I-gender
who 16 19 574 577 O
are 20 23 578 581 O
pregnant 24 32 582 590 B-pregnancy

Females 0 7 591 598 B-gender
of 8 10 599 601 O
child 11 16 602 607 O
- 16 17 607 608 O
bearing 17 24 608 615 O
potential 25 34 616 625 O
( 35 36 626 627 O
FOCBP 36 41 627 632 O
) 41 42 632 633 O

Has 0 3 634 637 O
had 4 7 638 641 O
menses 8 14 642 648 O
at 15 17 649 651 O
any 18 21 652 655 O
time 22 26 656 660 O
in 27 29 661 663 O
the 30 33 664 667 O
preceding 34 43 668 677 B-upper_bound
12 44 46 678 680 I-upper_bound
consecutive 47 58 681 692 I-upper_bound
months 59 65 693 699 I-upper_bound

Has 0 3 700 703 O
not 4 7 704 707 O
undergone 8 17 708 717 O
a 18 19 718 719 O
hysterectomy 20 32 720 732 B-treatment

History 0 7 733 740 O
of 8 10 741 743 O
primary 11 18 744 751 B-chronic_disease
immunodeficiency 19 35 752 768 I-chronic_disease
disease 36 43 769 776 I-chronic_disease

Hypothyroidism 0 14 777 791 B-chronic_disease
on 15 17 792 794 O
stable 18 24 795 801 O
doses 25 30 802 807 O
of 31 33 808 810 O
thyroid 34 41 811 818 B-treatment
replacement 42 53 819 830 I-treatment
therapy 54 61 831 838 I-treatment

Known 0 5 839 844 O
active 6 12 845 851 B-chronic_disease
or 13 15 852 854 I-chronic_disease
chronic 16 23 855 862 I-chronic_disease
viral 24 29 863 868 I-chronic_disease
hepatitis 30 39 869 878 I-chronic_disease

Major 0 5 879 884 O
medical 6 13 885 892 B-chronic_disease
conditions 14 24 893 903 I-chronic_disease
that 25 29 904 908 O
might 30 35 909 914 O
affect 36 42 915 921 O
study 43 48 922 927 O
participation 49 62 928 941 O

Ongoing 0 7 942 949 O
or 8 10 950 952 O
active 11 17 953 959 B-chronic_disease
infection 18 27 960 969 I-chronic_disease
requiring 28 37 970 979 O
systemic 38 46 980 988 B-treatment
treatment 47 56 989 998 I-treatment

Patients 0 8 999 1007 O
may 9 12 1008 1011 O
not 13 16 1012 1015 O
have 17 21 1016 1020 O
received 22 30 1021 1029 O
any 31 34 1030 1033 O
other 35 40 1034 1039 O
investigational 41 56 1040 1055 B-treatment
agents 57 63 1056 1062 I-treatment
within 64 70 1063 1069 O
4 71 72 1070 1071 B-upper_bound
weeks 73 78 1072 1077 I-upper_bound
prior 79 84 1078 1083 I-upper_bound
to 85 87 1084 1086 O
registration 88 100 1087 1099 O

Patients 0 8 1100 1108 O
must 9 13 1109 1113 O
exhibit 14 21 1114 1121 O
an 22 24 1122 1124 O
Eastern 25 32 1125 1132 B-clinical_variable
Cooperative 33 44 1133 1144 I-clinical_variable
Oncology 45 53 1145 1153 I-clinical_variable
Group 54 59 1154 1159 I-clinical_variable
( 60 61 1160 1161 I-clinical_variable
ECOG 61 65 1161 1165 I-clinical_variable
) 65 66 1165 1166 I-clinical_variable
performance 67 78 1167 1178 I-clinical_variable
status 79 85 1179 1185 I-clinical_variable
of 86 88 1186 1188 O
= 89 90 1189 1190 O
< 90 91 1190 1191 O
2 92 93 1192 1193 B-upper_bound

Patients 0 8 1194 1202 O
must 9 13 1203 1207 O
have 14 18 1208 1212 O
a 19 20 1213 1214 O
histologically 21 35 1215 1229 O
documented 36 46 1230 1240 O
( 47 48 1241 1242 O
either 48 54 1242 1248 O
primary 55 62 1249 1256 O
or 63 65 1257 1259 O
metastatic 66 76 1260 1270 O
site 77 81 1271 1275 O
) 81 82 1275 1276 O
diagnosis 83 92 1277 1286 O
of 93 95 1287 1289 O
breast 96 102 1290 1296 B-cancer
cancer 103 109 1297 1303 I-cancer
that 110 114 1304 1308 O
is 115 117 1309 1311 O
HER2 118 122 1312 1316 O
non 123 126 1317 1320 O
- 126 127 1320 1321 O
overexpressing 127 141 1321 1335 O
by 142 144 1336 1338 O
immunohistochemistry 145 165 1339 1359 B-clinical_variable
, 165 166 1359 1360 O
namely 167 173 1361 1367 O
0 174 175 1368 1369 B-lower_bound
or 176 178 1370 1372 O
1 179 180 1373 1374 B-upper_bound

Patients 0 8 1375 1383 O
must 9 13 1384 1388 O
have 14 18 1389 1393 O
measurable 19 29 1394 1404 O
disease 30 37 1405 1412 O
by 38 40 1413 1415 O
Response 41 49 1416 1424 O
Evaluation 50 60 1425 1435 O
Criteria 61 69 1436 1444 O
in 70 72 1445 1447 O
Solid 73 78 1448 1453 B-cancer
Tumors 79 85 1454 1460 I-cancer
( 86 87 1461 1462 O
RECIST 87 93 1462 1468 O
) 93 94 1468 1469 O
criteria 95 103 1470 1478 O

Patients 0 8 1479 1487 O
who 9 12 1488 1491 O
are 13 16 1492 1495 O
ER 17 19 1496 1498 O
negative 20 28 1499 1507 O
must 29 33 1508 1512 O
have 34 38 1513 1517 O
progressed 39 49 1518 1528 O
through 50 57 1529 1536 O
at 58 60 1537 1539 O
least 61 66 1540 1545 O
one 67 70 1546 1549 B-lower_bound
prior 71 76 1550 1555 I-lower_bound
chemotherapy 77 89 1556 1568 B-treatment
regimen 90 97 1569 1576 I-treatment
in 98 100 1577 1579 O
the 101 104 1580 1583 O
metastatic 105 115 1584 1594 B-cancer
setting 116 123 1595 1602 O

Patients 0 8 1603 1611 O
who 9 12 1612 1615 O
are 13 16 1616 1619 O
taking 17 23 1620 1626 O
any 24 27 1627 1630 O
herbal 28 34 1631 1637 B-treatment
( 35 36 1638 1639 I-treatment
alternative 36 47 1639 1650 I-treatment
) 47 48 1650 1651 I-treatment
medicines 49 58 1652 1661 I-treatment
are 59 62 1662 1665 O
NOT 63 66 1666 1669 O
eligible 67 75 1670 1678 O
for 76 79 1679 1682 O
participation 80 93 1683 1696 O

Patients 0 8 1697 1705 O
who 9 12 1706 1709 O
have 13 17 1710 1714 O
an 18 20 1715 1717 O
uncontrolled 21 33 1718 1730 O
intercurrent 34 46 1731 1743 B-chronic_disease
illness 47 54 1744 1751 I-chronic_disease

Patients 0 8 1752 1760 O
who 9 12 1761 1764 O
have 13 17 1765 1769 O
had 18 21 1770 1773 O
chemotherapy 22 34 1774 1786 B-treatment

Patients 0 8 1787 1795 O
with 9 13 1796 1800 O
a 14 15 1801 1802 O
history 16 23 1803 1810 O
of 24 26 1811 1813 O
or 27 29 1814 1816 O
active 30 36 1817 1823 O
autoimmune 37 47 1824 1834 B-chronic_disease
disease 48 55 1835 1842 I-chronic_disease

Platelets 0 9 1843 1852 B-clinical_variable
> 10 11 1853 1854 O
= 11 12 1854 1855 O
50,000 13 19 1856 1862 B-lower_bound
/ 19 20 1862 1863 I-lower_bound
mcl 20 23 1863 1866 I-lower_bound

Prior 0 5 1867 1872 O
severe 6 12 1873 1879 O
infusion 13 21 1880 1888 O
reaction 22 30 1889 1897 O
to 31 33 1898 1900 O
a 34 35 1901 1902 O
monoclonal 36 46 1903 1913 B-treatment
antibody 47 55 1914 1922 I-treatment

Prior 0 5 1923 1928 B-treatment
treatment 6 15 1929 1938 I-treatment
with 16 20 1939 1943 O
immune 21 27 1944 1950 B-treatment
therapy 28 35 1951 1958 I-treatment

Psoriasis 0 9 1959 1968 B-chronic_disease
not 10 13 1969 1972 O
requiring 14 23 1973 1982 O
systemic 24 32 1983 1991 B-treatment
therapy 33 40 1992 1999 I-treatment
within 41 47 2000 2006 O
the 48 51 2007 2010 O
past 52 56 2011 2015 B-upper_bound
3 57 58 2016 2017 I-upper_bound
years 59 64 2018 2023 I-upper_bound

Psychiatric 0 11 2024 2035 B-chronic_disease
illness 12 19 2036 2043 I-chronic_disease
/ 19 20 2043 2044 O
social 20 26 2044 2050 B-chronic_disease
situations 27 37 2051 2061 I-chronic_disease
that 38 42 2062 2066 O
would 43 48 2067 2072 O
limit 49 54 2073 2078 O
compliance 55 65 2079 2089 O
with 66 70 2090 2094 O
study 71 76 2095 2100 O
requirements 77 89 2101 2113 O

Radiation 0 9 2114 2123 B-treatment
therapy 10 17 2124 2131 I-treatment
must 18 22 2132 2136 O
be 23 25 2137 2139 O
completed 26 35 2140 2149 O
at 36 38 2150 2152 O
least 39 44 2153 2158 O
2 45 46 2159 2160 B-lower_bound
weeks 47 52 2161 2166 I-lower_bound
prior 53 58 2167 2172 I-lower_bound
to 59 61 2173 2175 O
study 62 67 2176 2181 O
entry 68 73 2182 2187 O

Total 0 5 2188 2193 B-clinical_variable
bilirubin 6 15 2194 2203 I-clinical_variable
= 16 17 2204 2205 O
< 17 18 2205 2206 O
1.5 19 22 2207 2210 B-upper_bound
times 23 28 2211 2216 I-upper_bound
the 29 32 2217 2220 I-upper_bound
institutional 33 46 2221 2234 I-upper_bound
upper 47 52 2235 2240 I-upper_bound
limit 53 58 2241 2246 I-upper_bound
of 59 61 2247 2249 I-upper_bound
normal 62 68 2250 2256 I-upper_bound
( 69 70 2257 2258 I-upper_bound
ULN 70 73 2258 2261 I-upper_bound
) 73 74 2261 2262 I-upper_bound

Uncontrolled 0 12 2263 2275 O
pulmonary 13 22 2276 2285 B-chronic_disease
, 22 23 2285 2286 O
renal 24 29 2287 2292 B-chronic_disease
, 29 30 2292 2293 O
or 31 33 2294 2296 O
hepatic 34 41 2297 2304 B-chronic_disease
dysfunction 42 53 2305 2316 I-chronic_disease

Vitamin 0 7 2317 2324 B-treatment
supplements 8 19 2325 2336 I-treatment
are 20 23 2337 2340 O
acceptable 24 34 2341 2351 O

Vitiligo 0 8 2352 2360 B-chronic_disease
or 9 11 2361 2363 O
alopecia 12 20 2364 2372 B-chronic_disease

Willingness 0 11 2373 2384 O
to 12 14 2385 2387 O
provide 15 22 2388 2395 O
a 23 24 2396 2397 O
fresh 25 30 2398 2403 O
biopsy 31 37 2404 2410 B-treatment
prior 38 43 2411 2416 I-treatment
to 44 46 2417 2419 O
study 47 52 2420 2425 O
enrollment 53 63 2426 2436 O
and 64 67 2437 2440 O
after 68 73 2441 2446 O
2 74 75 2447 2448 O
cycles 76 82 2449 2455 O
of 83 85 2456 2458 O
treatment 86 95 2459 2468 B-treatment

bilateral 0 9 2469 2478 B-treatment
oophorectomy 10 22 2479 2491 I-treatment

estrogen 0 8 2492 2500 B-clinical_variable
receptor 9 17 2501 2509 I-clinical_variable
( 18 19 2510 2511 I-clinical_variable
ER 19 21 2511 2513 I-clinical_variable
) 21 22 2513 2514 I-clinical_variable
positivity 23 33 2515 2525 O
is 34 36 2526 2528 O
defined 37 44 2529 2536 O
as 45 47 2537 2539 O
1 48 49 2540 2541 B-lower_bound
% 49 50 2541 2542 I-lower_bound
or 51 53 2543 2545 O
greater 54 61 2546 2553 O

for 0 3 2554 2557 O
at 4 6 2558 2560 O
least 7 12 2561 2566 O
1 13 14 2567 2568 B-lower_bound
month 15 20 2569 2574 I-lower_bound
after 21 26 2575 2580 I-lower_bound
local 27 32 2581 2586 B-treatment
therapy 33 40 2587 2594 I-treatment
( 41 42 2595 2596 O
radiation 42 51 2596 2605 B-treatment
or 52 54 2606 2608 O
surgery 55 62 2609 2616 B-treatment
) 62 63 2616 2617 O

for 0 3 2618 2621 O
the 4 7 2622 2625 O
duration 8 16 2626 2634 O
of 17 19 2635 2637 O
study 20 25 2638 2643 O
participation 26 39 2644 2657 O
, 39 40 2657 2658 O
and 41 44 2659 2662 O
for 45 48 2663 2666 O
number 49 55 2667 2673 O
( 56 57 2674 2675 O
# 57 58 2675 2676 O
) 58 59 2676 2677 O
days 60 64 2678 2682 O
following 65 74 2683 2692 O
completion 75 85 2693 2703 O
of 86 88 2704 2706 O
therapy 89 96 2707 2714 B-treatment

have 0 4 2715 2719 O
received 5 13 2720 2728 O
at 14 16 2729 2731 O
least 17 22 2732 2737 O
one 23 26 2738 2741 B-lower_bound
line 27 31 2742 2746 O
of 32 34 2747 2749 O
chemotherapy 35 47 2750 2762 B-treatment
in 48 50 2763 2765 O
the 51 54 2766 2769 O
metastatic 55 65 2770 2780 O
setting 66 73 2781 2788 O

human 0 5 2789 2794 B-chronic_disease
immunodeficiency 6 22 2795 2811 I-chronic_disease
virus 23 28 2812 2817 I-chronic_disease
( 29 30 2818 2819 I-chronic_disease
HIV 30 33 2819 2822 I-chronic_disease
) 33 34 2822 2823 I-chronic_disease

including 0 9 2824 2833 O
but 10 13 2834 2837 O
not 14 17 2838 2841 O
limited 18 25 2842 2849 O
to 26 28 2850 2852 O
cluster 29 36 2853 2860 O
of 37 39 2861 2863 O
differentiation 40 55 2864 2879 O
[ 56 57 2880 2881 B-treatment
CD]137 57 63 2881 2887 I-treatment
, 63 64 2887 2888 O
OX40 65 69 2889 2893 B-treatment
, 69 70 2893 2894 O
programmed 71 81 2895 2905 B-treatment
death 82 87 2906 2911 I-treatment
[ 88 89 2912 2913 I-treatment
PD]-1 89 94 2913 2918 I-treatment
, 94 95 2918 2919 O
PD 96 98 2920 2922 B-treatment
- 98 99 2922 2923 I-treatment
L1 99 101 2923 2925 I-treatment
or 102 104 2926 2928 O
cytotoxic 105 114 2929 2938 B-treatment
T 115 116 2939 2940 I-treatment
- 116 117 2940 2941 I-treatment
lymphocyte 117 127 2941 2951 I-treatment
antigen 128 135 2952 2959 I-treatment
4 136 137 2960 2961 I-treatment
[ 138 139 2962 2963 I-treatment
CTLA4 139 144 2963 2968 I-treatment
] 144 145 2968 2969 I-treatment
inhibitors 146 156 2970 2980 I-treatment

leptomeningeal 0 14 2981 2995 B-cancer
disease 15 22 2996 3003 I-cancer

males 0 5 3004 3009 B-gender
must 6 10 3010 3014 O
agree 11 16 3015 3020 B-contraception_consent
to 17 19 3021 3023 I-contraception_consent
use 20 23 3024 3027 I-contraception_consent
2 24 25 3028 3029 I-contraception_consent
methods 26 33 3030 3037 I-contraception_consent
of 34 36 3038 3040 I-contraception_consent
adequate 37 45 3041 3049 I-contraception_consent
contraception 46 59 3050 3063 I-contraception_consent
prior 60 65 3064 3069 O
to 66 68 3070 3072 O
study 69 74 3073 3078 O
entry 75 80 3079 3084 O

metastatic 0 10 3085 3095 B-clinical_variable
lesion 11 17 3096 3102 I-clinical_variable
( 18 19 3103 3104 O
ratio 19 24 3104 3109 O
< 25 26 3110 3111 O
2 27 28 3112 3113 B-upper_bound
and 29 32 3114 3117 O
HER2 33 37 3118 3122 B-clinical_variable
copy 38 42 3123 3127 I-clinical_variable
number 43 49 3128 3134 I-clinical_variable
< 50 51 3135 3136 O
4 52 53 3137 3138 B-upper_bound
) 53 54 3138 3139 O

must 0 4 3140 3144 O
have 5 9 3145 3149 O
completed 10 19 3150 3159 O
any 20 23 3160 3163 O
prescribed 24 34 3164 3174 O
steroid 35 42 3175 3182 B-treatment
taper 43 48 3183 3188 O

patients 0 8 3189 3197 O
must 9 13 3198 3202 O
be 14 16 3203 3205 O
off 17 20 3206 3209 O
any 21 24 3210 3213 O
such 25 29 3214 3218 O
medications 30 41 3219 3230 B-treatment
by 42 44 3231 3233 O
the 45 48 3234 3237 O
time 49 53 3238 3242 O
of 54 56 3243 3245 O
registration 57 69 3246 3258 O
for 70 73 3259 3262 O
at 74 76 3263 3265 O
least 77 82 3266 3271 O
2 83 84 3272 3273 B-lower_bound
weeks 85 90 3274 3279 I-lower_bound

patients 0 8 3280 3288 O
who 9 12 3289 3292 O
are 13 16 3293 3296 O
ER 17 19 3297 3299 B-cancer
positive 20 28 3300 3308 I-cancer
must 29 33 3309 3313 O
have 34 38 3314 3318 O
progressed 39 49 3319 3329 O
through 50 57 3330 3337 O
standard 58 66 3338 3346 B-treatment
hormone 67 74 3347 3354 I-treatment
therapy 75 82 3355 3362 I-treatment
options 83 90 3363 3370 O

radiated 0 8 3371 3379 O
lesions 9 16 3380 3387 O
may 17 20 3388 3391 O
not 21 24 3392 3395 O
serve 25 30 3396 3401 O
as 31 33 3402 3404 O
measurable 34 44 3405 3415 O
disease 45 52 3416 3423 O
unless 53 59 3424 3430 O
they 60 64 3431 3435 O
have 65 69 3436 3440 O
been 70 74 3441 3445 O
radiated 75 83 3446 3454 O
over 84 88 3455 3459 O
12 89 91 3460 3462 B-lower_bound
months 92 98 3463 3469 I-lower_bound
prior 99 104 3470 3475 I-lower_bound
to 105 107 3476 3478 O
enrollment 108 118 3479 3489 O

radiotherapy 0 12 3490 3502 B-treatment
within 13 19 3503 3509 O
2 20 21 3510 3511 B-upper_bound
weeks 22 27 3512 3517 I-upper_bound
prior 28 33 3518 3523 I-upper_bound
to 34 36 3524 3526 O
entering 37 45 3527 3535 O
the 46 49 3536 3539 O
study 50 55 3540 3545 O

should 0 6 3546 3552 O
a 7 8 3553 3554 O
female 9 15 3555 3561 B-gender
patient 16 23 3562 3569 O
become 24 30 3570 3576 B-pregnancy
pregnant 31 39 3577 3585 I-pregnancy

suspect 0 7 3586 3593 O
she 8 11 3594 3597 O
is 12 14 3598 3600 O
pregnant 15 23 3601 3609 B-pregnancy
while 24 29 3610 3615 O
participating 30 43 3616 3629 O
in 44 46 3630 3632 O
this 47 51 3633 3637 O
study 52 57 3638 3643 O

the 0 3 3644 3647 O
tumor 4 9 3648 3653 B-cancer
must 10 14 3654 3658 O
be 15 17 3659 3661 O
non 18 21 3662 3665 O
- 21 22 3665 3666 O
gene 22 26 3666 3670 O
amplified 27 36 3671 3680 O
by 37 39 3681 3683 O
fluorescence 40 52 3684 3696 B-treatment
in 53 55 3697 3699 I-treatment
situ 56 60 3700 3704 I-treatment
hybridization 61 74 3705 3718 I-treatment
( 75 76 3719 3720 I-treatment
FISH 76 80 3720 3724 I-treatment
) 80 81 3724 3725 I-treatment
performed 82 91 3726 3735 O
upon 92 96 3736 3740 O
the 97 100 3741 3744 O
primary 101 108 3745 3752 B-cancer
tumor 109 114 3753 3758 I-cancer

therefore 0 9 3759 3768 O
has 10 13 3769 3772 O
not 14 17 3773 3776 O
been 18 22 3777 3781 O
naturally 23 32 3782 3791 O
postmenopausal 33 47 3792 3806 B-clinical_variable
for 48 51 3807 3810 O
> 52 53 3811 3812 O
12 54 56 3813 3815 B-lower_bound
months 57 63 3816 3822 I-lower_bound

those 0 5 3823 3828 O
who 6 9 3829 3832 O
have 10 14 3833 3837 O
not 15 18 3838 3841 O
recovered 19 28 3842 3851 O
from 29 33 3852 3856 O
adverse 34 41 3857 3864 O
events 42 48 3865 3871 O
due 49 52 3872 3875 O
to 53 55 3876 3878 O
agents 56 62 3879 3885 O
administered 63 75 3886 3898 O
more 76 80 3899 3903 O
than 81 85 3904 3908 O
4 86 87 3909 3910 B-lower_bound
weeks 88 93 3911 3916 I-lower_bound
earlier 94 101 3917 3924 I-lower_bound
are 102 105 3925 3928 O
not 106 109 3929 3932 O
eligible 110 118 3933 3941 O

tuberculosis 0 12 3942 3954 B-chronic_disease

uncontrolled 0 12 3955 3967 O
pulmonary 13 22 3968 3977 B-chronic_disease
, 22 23 3977 3978 O
renal 24 29 3979 3984 B-chronic_disease
, 29 30 3984 3985 O
or 31 33 3986 3988 O
hepatic 34 41 3989 3996 B-chronic_disease
dysfunction 42 53 3997 4008 I-chronic_disease
, 53 54 4008 4009 O
uncontrolled 55 67 4010 4022 B-chronic_disease
infection 68 77 4023 4032 I-chronic_disease

within 0 6 4033 4039 O
12 7 9 4040 4042 B-upper_bound
months 10 16 4043 4049 I-upper_bound
of 17 19 4050 4052 O
their 20 25 4053 4058 O
last 26 30 4059 4063 B-treatment
adjuvant 31 39 4064 4072 I-treatment
systemic 40 48 4073 4081 I-treatment
treatment 49 58 4082 4091 I-treatment

